Cardiokine's Series B Round

Cardiokine raised a round of funding on April 12, 2006.

CardioKine develops pharmaceuticals for cardio-renal diseases. Their lead product lixivaptan is a sodium-sparing diuretic for the treatment of heart failure and electrolyte imbalances. In Decembe…

Articles about Cardiokine's Series B Round: